back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-03 09:15 Tx date 2025-05-09 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
58 - Expiration of rights
|
-1,750,000 vol |
550,000 | |
| Filed 2025-05-21 19:10 Tx date 2025-05-09 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
58 - Expiration of rights
|
-622,096 vol |
500,000 | |
| Filed 2025-05-21 19:09 Tx date 2025-05-09 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
58 - Expiration of rights
|
-666,666 vol |
1,122,096 | |
| Filed 2025-05-21 19:06 Tx date 2025-05-09 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
58 - Expiration of rights
|
-333,333 vol |
1,788,762 | |
| Filed 2025-05-21 18:52 Tx date 2025-03-11 |
$KNE
Kane Biotech Inc. |
Renaud, Richard J.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-156,250
-1,562,500 vol $0.10 each |
0 | |
| Filed 2025-05-06 14:18 Tx date 2025-05-05 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$200,000
+2,000,000 vol $0.10 each |
2,932,000 | |
| Filed 2025-05-06 08:41 Tx date 2025-05-05 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,000,000
+10,000,000 vol $0.10 each |
27,289,711 | |
| Filed 2025-01-23 18:39 Tx date 2025-01-17 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$200,000
+2,000,000 vol $0.10 each |
8,383,142 | |
| Filed 2025-01-23 12:30 Tx date 2025-01-17 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$60,000
+600,000 vol $0.10 each |
932,000 | |
| Filed 2025-01-23 12:23 Tx date 2025-01-17 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$6,000
+60,000 vol $0.10 each |
||
| Filed 2025-01-18 07:16 Tx date 2025-01-17 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$100,000
+1,000,000 vol $0.10 each |
17,289,711 | |
| Filed 2025-01-18 07:11 Tx date 2025-01-17 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
1,085,404 | |
| Filed 2024-10-01 22:28 Tx date 2024-10-01 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,250
+242,000 vol $0.125 each |
332,000 | |
| Filed 2024-09-17 16:48 Tx date 2024-09-13 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,250
+90,000 vol $0.125 each |
90,000 | |
| Filed 2024-09-17 16:47 Tx date 2024-02-21 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-09-12 09:22 Tx date 2024-09-11 |
$KNE
Kane Biotech Inc. |
Renaud, Richard J.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$250,000
+2,500,000 vol $0.10 each |
17,130,333 | |
| Filed 2024-09-12 09:08 Tx date 2024-09-11 |
$KNE
Kane Biotech Inc. |
Renaud, Richard J.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-250,000
-2,500,000 vol $0.10 each |
1,562,500 | |
| Filed 2024-08-01 12:02 Tx date 2024-07-14 |
$KNE
Kane Biotech Inc. |
Coleman, John
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
666,667 | ||
| Filed 2024-07-29 12:59 Tx date 2024-07-29 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,250
+150,000 vol $0.135 each |
6,383,142 | |
| Filed 2024-07-23 12:26 Tx date 2024-07-15 |
$KNE
Kane Biotech Inc. |
Morin, Georges
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+333,333 vol |
1,416,665 |